1w30: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1w30" size="450" color="white" frame="true" align="right" spinBox="true" caption="1w30, resolution 1.90Å" /> '''PYRR OF MYCOBACTERIU...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1w30.gif|left|200px]]<br /><applet load="1w30" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1w30.gif|left|200px]]<br /><applet load="1w30" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1w30, resolution 1.90&Aring;" />
caption="1w30, resolution 1.90&Aring;" />
'''PYRR OF MYCOBACTERIUM TUBERCULOSIS AS A POTENTIAL DRUG TARGET'''<br />
'''PYRR OF MYCOBACTERIUM TUBERCULOSIS AS A POTENTIAL DRUG TARGET'''<br />


==Overview==
==Overview==
The Mycobacterium tuberculosis pyrR gene (Rv1379) encodes a protein that, regulates the expression of pyrimidine-nucleotide biosynthesis (pyr) genes, in a UMP-dependent manner. Because pyrimidine biosynthesis is an essential, step in the progression of TB, the gene product pyrR is an attractive, antitubercular drug target. The 1.9 A native structure of Mtb pyrR, determined by the TB Structural Genomics Consortium facilities in trigonal, space group P3(1)21 is reported, with unit-cell parameters a = 66.64, c =, 154.72 A at 120 K and two molecules in the asymmetric unit. The, three-dimensional structure and residual uracil phosphoribosyltransferase, activity point to a common PRTase ancestor for pyrR. However, while PRPP-, and UMP-binding sites have been retained in Mtb pyrR, a distinct dimer, interaction among subunits creates a deep positively charged cleft capable, of binding pyr mRNA. In silico screening of pyrimidine-nucleoside analogs, has revealed a number of potential lead compounds that, if bound to Mtb, pyrR, could facilitate transcriptional attenuation, particularly, cyclopentenyl nucleosides.
The Mycobacterium tuberculosis pyrR gene (Rv1379) encodes a protein that regulates the expression of pyrimidine-nucleotide biosynthesis (pyr) genes in a UMP-dependent manner. Because pyrimidine biosynthesis is an essential step in the progression of TB, the gene product pyrR is an attractive antitubercular drug target. The 1.9 A native structure of Mtb pyrR determined by the TB Structural Genomics Consortium facilities in trigonal space group P3(1)21 is reported, with unit-cell parameters a = 66.64, c = 154.72 A at 120 K and two molecules in the asymmetric unit. The three-dimensional structure and residual uracil phosphoribosyltransferase activity point to a common PRTase ancestor for pyrR. However, while PRPP- and UMP-binding sites have been retained in Mtb pyrR, a distinct dimer interaction among subunits creates a deep positively charged cleft capable of binding pyr mRNA. In silico screening of pyrimidine-nucleoside analogs has revealed a number of potential lead compounds that, if bound to Mtb pyrR, could facilitate transcriptional attenuation, particularly cyclopentenyl nucleosides.


==About this Structure==
==About this Structure==
1W30 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Active as [http://en.wikipedia.org/wiki/Uracil_phosphoribosyltransferase Uracil phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.9 2.4.2.9] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1W30 OCA].  
1W30 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Active as [http://en.wikipedia.org/wiki/Uracil_phosphoribosyltransferase Uracil phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.9 2.4.2.9] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1W30 OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Uracil phosphoribosyltransferase]]
[[Category: Uracil phosphoribosyltransferase]]
[[Category: Castro, P.]]
[[Category: Castro, P.]]
[[Category: Kantardjieff, K.A.]]
[[Category: Kantardjieff, K A.]]
[[Category: Kim, C.Y.]]
[[Category: Kim, C Y.]]
[[Category: Lekin, T.]]
[[Category: Lekin, T.]]
[[Category: Rho, B.S.]]
[[Category: Rho, B S.]]
[[Category: Rupp, B.]]
[[Category: Rupp, B.]]
[[Category: Segelke, B.W.]]
[[Category: Segelke, B W.]]
[[Category: TBSGC, TB.Structural.Genomics.Consortium.]]
[[Category: TBSGC, TB Structural Genomics Consortium.]]
[[Category: Terwilliger, T.]]
[[Category: Terwilliger, T.]]
[[Category: Vasquez, C.]]
[[Category: Vasquez, C.]]
[[Category: Warfel, N.N.]]
[[Category: Warfel, N N.]]
[[Category: glycosyltransferase]]
[[Category: glycosyltransferase]]
[[Category: protein structure initiative]]
[[Category: protein structure initiative]]
Line 34: Line 34:
[[Category: transferase]]
[[Category: transferase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 05:12:51 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:39:54 2008''